0 a-PE epitope prediction
Ended Awarded
- Contract number
- HHSN261NFA73740
- Awardee
-
Spring Valley Laboratories, Inc. UEI HJAXC6JCFXM8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,719
Award facts
- Contract value
-
- $2,718.90 Current, with exercised options
- $0.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Not on record Potential, with all options
- Funding agency
- Office of the Director National Institutes of Health, Department of Health and Human Services
- NAICS code
- Not on record
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 0 offers Simplified Acquisition
- Pricing
- Other
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN261NFA73740?
HHSN261NFA73740 was awarded to Spring Valley Laboratories, Inc. by National Cancer Institute (National Institutes of Health) on January 19, 2006.
How much is contract HHSN261NFA73740 worth?
The government has obligated $2,719 on HHSN261NFA73740.
Which agency awarded contract HHSN261NFA73740?
National Cancer Institute (National Institutes of Health) awarded HHSN261NFA73740, with funding from Office of the Director (National Institutes of Health).
Is contract HHSN261NFA73740 an order under another contract?
Yes. HHSN261NFA73740 is a BPA call under HHSN263200400061776B, a blanket purchase agreement.
Was contract HHSN261NFA73740 competed?
The extent of competition for HHSN261NFA73740 was full and open competition. The government received 0 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award